Related Experiment Videos
Melan-A/MART-1-specific CD8 T cells: from thymus to tumor
Mikaël J Pittet1, Alfred Zippelius, Danila Valmori
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland.
Trends in Immunology
|July 10, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.
bioRxiv : the preprint server for biology·2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.
Journal for immunotherapy of cancer·2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.
Communications medicine·2026
The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Nature biomedical engineering·2026
Micrometastasis as a distinct immunobiological state and therapeutic target.
Trends in immunology·2026
Neutrophil-T cell dynamics predict tuberculosis outcome.
Trends in immunology·2026
CARM1: an epigenetic brake on cDC1-mediated antitumor immunity.
Trends in immunology·2026
Neurons as cytokine sensors in the central nervous system.
Trends in immunology·2026
Breast milk IgG: 'it does a baby good'.
Trends in immunology·2026
Mitochondrial Complex II in the regulation of immunopathology.
Trends in immunology·2026
Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.
Frontiers in oncology·2026
Imaging features of soft tissue hibernoma: a review of 73 cases.
Skeletal radiology·2026